Q2 2026 · Form 13F Ledger数据来源:SEC EDGAR  
H

HOLDER.TOP

谁持有什么——美股机构持仓的季度账本。
EN · 简 · 繁
机构 / Stonepine Capital Management, LLC
Form 13F · Q2 2026

Stonepine Capital Management, LLC

CIK 1440771申报日 2026-08-1713F-HR/A 在 EDGAR 查看原始申报 ↗
$1.8亿
申报组合市值
87
持仓数量
12
Quarters on record
Top 50
持仓数量

Stonepine Capital Management, LLC——持仓

共 87 个持仓中的前 50 名,按申报市值排名。股数变动与上一季度对比。
#证券股数股数环比市值占其组合
1VSTM Verastem Inc3.3M+1.4%$1280万7.2%
2EOLS Evolus Inc1.6M−9.6%$1104万6.2%
3TENX Tenax Therapeutics Inc660,000−32.3%$960万5.4%
4NKTR Nektar Therapeutics120,654+41.9%$842万4.8%
5ADMA Adma Biologics Inc740,000+0.0%$619万3.5%
6CAMP Camp4 Therapeutics Corp1.4M+0.0%$607万3.4%
7ELOX Eloxx Pharmaceuticals Inc397,160—$551万3.1%
8KZIA Kazia Therapeutics Ltd345,179+0.0%$486万2.7%
9INDIVIOR PHARMACEUTICALS INC Indivior Pharmaceuticals Inc100,000—$410万2.3%
10CRBP Corbus Pharmaceuticals Hldgs425,000+10.8%$399万2.2%
11MSLE Satellos Bioscience Inc491,624+391.6%$372万2.1%
12ZVRA Zevra Therapeutics Inc258,701−46.1%$371万2.1%
13ABEO Abeona Therapeutics Inc557,284−25.4%$344万1.9%
14EDSA Edesa Biotech Inc456,439+1421.5%$319万1.8%
15CABA Cabaletta Bio Inc917,100+1734.2%$285万1.6%
16ANTX An2 Therapeutics Inc551,692−22.7%$267万1.5%
17XLO Xilio Therapeutics Inc225,994+252.2%$217万1.2%
18ACET Adicet Bio Inc245,518+10.6%$212万1.2%
19TELA Tela Bio Inc2.7M+1.7%$200万1.1%
20AYTU Aytu Biopharma Inc912,921+15.2%$196万1.1%
21CRIS Curis Inc3.3M−11.1%$173万1.0%
22SPRB Spruce Biosciences Inc28,795—$155万0.9%
23OKYO Okyo Pharma Ltd862,996+1.5%$129万0.7%
24KTTA Pasithea Therapeutics Corp2.2M+164.8%$113万0.6%
25SLGL Sol-Gel Technologies Ltd14,469−47.9%$107万0.6%
26LUNG Pulmonx Corp815,436+6.1%$106万0.6%
27XFOR X4 Pharmaceuticals Inc224,989−32.9%$105万0.6%
28INAB In8Bio Inc695,287+4.8%$98万0.6%
29MLTX Moonlake Immunotherapeutics50,000—$97万0.5%
30QNRX Quoin Pharmaceuticals Ltd199,486+273.2%$97万0.5%
31MXCT Maxcyte Inc751,606−25.2%$92万0.5%
32PHAT Phathom Pharmaceuticals Inc85,010+70.0%$92万0.5%
33AZTR Azitra Inc5.3M—$89万0.5%
34CNTB Connect Biopharma Hldgs Ltd364,254+17.5%$87万0.5%
35HELP Cybin Inc129,280−3.6%$85万0.5%
36RARE Ultragenyx Pharmaceutical In25,000—$83万0.5%
37IKT Inhibikase Therapeutics Inc396,179−58.6%$80万0.5%
38ZNTL Zentalis Pharmaceuticals Inc161,583−40.0%$78万0.4%
39CTMX Cytomx Therapeutics Inc.205,000+2.5%$77万0.4%
40NVCT Nuvectis Pharma Inc40,000—$74万0.4%
41CBIO Crescent Biopharma Inc.40,000−52.9%$72万0.4%
42PMVP Pmv Pharmaceuticals Inc536,086−24.3%$72万0.4%
43ORKA Oruka Therapeutics Inc7,500—$71万0.4%
44RADX Radiopharm Theranostics Ltd51.0M+0.0%$67万0.4%
45OKUR Onkure Therapeutics Inc130,684−1.4%$60万0.3%
46NGEN Nervgen Pharma Corp271,678—$56万0.3%
47CALC Calcimedica Inc622,432—$54万0.3%
48ARVN Arvinas Inc60,000+118.2%$50万0.3%
49BIOA Bioage Labs Inc20,000−60.0%$49万0.3%
50IRD Opus Genetics Inc100,718+46.6%$41万0.2%
来源:经 SEC EDGAR 的 Form 13F 申报。持仓截至 2026 年 6 月 30 日。期权(看涨/看跌)不计入股数。